top of page
  • mirifinch

Vaccine developers warned of "ADE" - could it cause catastrophe this winter?

“I understand the importance of accelerating timelines for vaccines in general, but from everything I know, this is not the vaccine to be doing it with." So were the prescient words of scientist and vaccine developer, Dr. Peter Hotez, in 2020, regarding the coronavirus (COVID-19) vaccines, whilst they were still in development. Hotez, who serves as the dean of the National School of Tropical Medicine at Baylor College of Medicine, should know: he and his team had tried and failed to develop coronavirus vaccines in the past, and Hotez issued an urgent caution to scientists trying to fast-track Covid vaccines, warning that cutting corners and sidestepping vital long-term animal studies could have lethal consequences. Hotez had previously worked on the development of a vaccine for SARS (Severe Acute Respiratory Syndrome), a type of coronavirus, and found that some vaccinated animals developed more severe disease compared with unvaccinated animals when they were exposed to live viruses. This is a condition known as immune enhancement, or antibody dependent enhancement - ADE. While the idea of "immune enhancement" may sound like a positive, it is anything but - in this context, immune "enhancement" means potential catastrophic immune overreaction. “There is a risk of immune enhancement,” warned Hotez, when commenting on the Covid vaccines still in trials. “The way you reduce that risk is first you show it does not occur in laboratory animals.” This was never shown with the Covid vaccines. Sadly, Hotez' concerns have proven all too valid, with evidence showing that the risk of ADE in COVID-19 vaccine recipients is significant. A 2021 study published in the National Library of Medicine concluded:

"The specific and significant COVID-19 risk of ADE should have been and should be prominently and independently disclosed to research subjects currently in vaccine trials, as well as those being recruited for the trials and future patients after vaccine approval, in order to meet the medical ethics standard of patient comprehension for informed consent." What this essentially means is that those who have received coronavirus vaccines, could be at risk of a much more severe reaction to live viruses than their unvaccinated counterparts. This is especially concerning when one considers that secondary school students - many of whom received the COVID-19 vaccines via their schools - are this year being offered, for the first time ever, the flu nasal spray, which contains a variety of live viruses, including a new B-strain which has never been added to the children's nasal spray before. It is therefore feasible to believe that some of these children's immune systems could dramatically overreact to these viruses as a result of the ADE they may have developed from their Covid vaccines. ADE is a disorder of the immune system, which effectively renders a person immunodeficient, in that their immune system is not functioning in the normal or optimal way. It is already official medical advice not to give the flu nasal spray to immunodeficient children. To quote from the University of Oxford: "The nasal flu spray should not be given to anyone who is severely immunodeficient (so that their immune system cannot control viral infections in the normal way)... The resource continues:

"Children who have been vaccinated with the nasal spray should avoid close contact with people who have very severely weakened immune systems (for example, bone marrow transplant patients requiring isolation in a protective environment) for about two weeks following vaccination. If it is not possible for a child to avoid contact with someone who is severely immunosuppressed (for example, because they live in the same house), the child should not receive the nasal flu vaccine." This means that even children who do not receive the nasal flu vaccine, could be at risk from others in close quarters (such as schoolmates) who do. There is no data at all to establish that it is safe to give the flu nasal spray to children who have received COVID-19 vaccinations, children who may have developed ADE, and therefore could have a catastrophic reaction to the live viruses contained within the flu spray. These reactions could be labelled by the government - not as vaccine reactions - but as evidence of "a new variant" that another lockdown is required to contain. Ministers have already warned us that future pandemics and lockdowns are to be expected very soon. Please help us raise awareness of this critical issue by sharing this news bulletin with family and friends and by handing out our awareness-raising leaflet. The flu spray programme commenced this month (September) and will run until December 2023 so there is still time to get this information out into the local community and to warn parents of the potential risks to their children from receiving this spray (or being near others who do). Thank you for your support in helping us spread the critical message that, when it comes to children's health especially, informed consent really does matter.


Recent Posts

See All


bottom of page